NCT05858229View on ClinicalTrials.gov

Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Squamous Cell CarcinomaRP1

Interventions

DRUG

RP1

Recombinant Herpes Simplex Virus Type 1 - hGM CSF/GALV-GP-R-

Trial Locations (1)

14564

RECRUITING

Rochester Dermatologic Surgery, Victor

All Listed Sponsors

lead

Sherrif Ibrahim

OTHER